Botanical species · safety record

Erysimum ×

The EFSA Compendium of Botanicals holds 11 constituent measurements for Erysimum ×. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Erysimum × cheiri (L.) Crantz

11Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Also recorded as

Cheiranthus x cheiri (L.) Crantz

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Cardenolides	Aerial part of plants	—	—	Unspecified	Resolve DOI
Cardenolides	Seed	—	—	Unspecified	Resolve DOI
Glucosinolates	Seed	—	—	Unspecified	Resolve DOI
Glucosinolates	Seed	Solvent extraction	13.1 Percent	GC-FID	Resolve DOI
Glucosinolates	Seed	Solvent extraction	84.4 Percent	GC-FID	Resolve DOI
Glucosinolates	Aerial part of plants	—	—	Unspecified	Resolve DOI
Glucosinolates	Seed	Solvent extraction	66 Millimole/kilogram	HPLC-MS/MS	Resolve DOI
Salicylic acid	Flower	Essential oil	—	Unspecified	Resolve DOI
1,8-cineole	Flower	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Calystegin a3	Leaves	Solvent extraction	20 Microgram/gram	GC-MS	No resolvable identifier
Camphor	Flower	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Mosleh, Ghazaleh., Badr, Parmis., Azadi, Amir., Abolhassanzadeh, Zohreh., Hosseini, Seyed Vahid., Mohagheghzadeh, Abdolali. Wallflower (Erysimum cheiri (L.) Crantz) from Past to Future. Research journal of pharmacognosy, 2019, vol. 6, no. 2, p. 85-95. DOI
Bahmanzadegan, Atefeh., Rowshan, Vahid. Static Headspace Analysis and Polyphenol Content of Tagetes erecta, Matthiola incana, Erysimum cheiri, Gaillardia grandiflora and Dahlia pinnata in Iran. Analytical chemistry letters, 2018, vol. 8, no. 6, p. 794-802.
Vaughn, SF., Berhow, MA. Glucosinolate hydrolysis products from various plant sources: pH effects, isolation, and purification . Industrial crops and products, 2005, vol. 21, no. 2, p. 193-202. DOI
Brock, Andrea., Herzfeld, Tobias., Paschke, Reinhard., Koch, Marcus., Draeger, Birgit. Brassicaceae contain nortropane alkaloids. Phytochemistry (elsevier), 2006, vol. 67, no. 18, p. 2050-2057.
Matthaus, B., Luftmann, H. Glucosinolates in members of the family Brassicaceae: Separation and identification by LC/ESI-MS-MS . Journal of agricultural and food chemistry, 2000, vol. 48, no. 6, p. 2234-2239. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature